Evidence map›Paper›PMID 28533931›Full record

ArticleAmerican journal of cardiovascular disease2017

Altered expression of

Shuo Li, Kang Guo, Junfang Wu, Zhikun Guo, Airong Li

Open access · greenAbstract read
In one paragraph

Article in American journal of cardiovascular disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Effects of Enalapril on TLR2/NF-Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuo LiHenan Key Laboratory of Tissue Regeneration, Xinxiang Medical UniversityXinxiang 453003, Henan, P. R. China.
Kang GuoDepartment of Oncology, The Third Affiliated Hospital, Xinxiang Medical UniversityXinxiang 453003, Henan, P. R. China.
Junfang WuMorphological Laboratory, Basic Medical College, Xinxiang Medical UniversityXinxiang 453003, Henan, P. R. China.
Zhikun GuoHenan Key Laboratory of Tissue Regeneration, Xinxiang Medical UniversityXinxiang 453003, Henan, P. R. China.
Airong LiHenan Key Laboratory of Tissue Regeneration, Xinxiang Medical UniversityXinxiang 453003, Henan, P. R. China.
Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A small number of cardiac stem cells that express the c-Kit and Nanog biomarkers can be differentiated into myocardial cells, which suggests that these stem cells may be able to repair damage and provide an internal reserve for tissue regeneration. It is unknown, however, whether the levels of myocardial stem cells are altered after heart failure (HF), and whether HF affects the myocardial regenerative ability. In this study, to address this question, we developed a rat model of chronic HF induced by Adriamycin, and examined the morphological changes in c-Kit and Nanog-expressing stem cells in heart tissue of normal and HF rats. We further measured levels of c-Kit and Nanog expression in the hearts of HF vs. healthy control rats using immunohistochemistry, immunofluorescence, and semi-quantitative reverse transcription (RT)-PCR methods. c-Kit and Nanog were expressed in both normal and HF rats; c-Kit was mainly found in and around the epicardial region, whereas Nanog was primarily expressed in vascular endothelium of some myocardial cells and in stem cells. However, expression of both c-Kit and Nanog was significantly decreased in myocardial cells from HF rats, which may be reflective of reduced myocardial regeneration capacity. These findings indicate that HF not only seriously damages the heart muscle cells, but also the cardiac stem cells. This reduced pool of cardiac stem cells and their related factors is likely to be deleterious for tissue repair after myocardial injury.

Indexed as

Adriamycinc-Kitheart failureimmunohistochemistryMyocardial cellsNanogstem cells

Identifiers

PMID28533931
PMCPMC5435606
OpenAlexW2976421411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.